- AU$14.14m
- AU$13.98m
- AU$7.04m
- 41
- 41
- 26
- 27
Annual balance sheet for Control Bionics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 12.3 | 5.21 | 0.935 | 0.981 | 0.595 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.01 | 1.48 | 1.98 | 1.45 | 1.97 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13.7 | 8.61 | 3.87 | 3.76 | 3.17 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.534 | 0.734 | 0.72 | 1.22 | 0.844 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 18.4 | 13.4 | 8.7 | 9.03 | 8.23 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.17 | 1.36 | 1.47 | 2.4 | 2.55 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.19 | 1.51 | 1.55 | 2.76 | 2.72 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.2 | 11.9 | 7.15 | 6.27 | 5.51 |
| Total Liabilities & Shareholders' Equity | 18.4 | 13.4 | 8.7 | 9.03 | 8.23 |
| Total Common Shares Outstanding |